Literature DB >> 25070000

MicroRNA-181 inhibits glioma cell proliferation by targeting cyclin B1.

Fei Wang1, Ji-Yong Sun2, You-Hou Zhu1, Ning-Tao Liu1, Yi-Fang Wu1, Fei Yu1.   

Abstract

Small non‑coding RNAs from the microRNA family (miRs) are important elements in the posttranscriptional control of gene expression. miRs are known to regulate numerous cellular processes and are of crucial importance during development and in pathological conditions, including tumor initiation and progression. In the present study, the expression level of miR‑181 was reduced in glioma tissues compared with the adjacent normal tissues. The enforced expression of miR‑181 was able to inhibit cell proliferation in U251 and SHG‑44 cells, while antisense miR‑181 oligonucleotides (antisense miR‑181) enhanced cell proliferation. At the molecular level, these results further revealed that the expression of cyclin B1, a positive cell‑cycle regulator, was negatively regulated by miR‑181. Therefore, the data reported in the present study demonstrates that miR‑181 is an important regulator in glioma. These results may contribute to improving the understanding of the key misregulated miRNAs in glioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070000     DOI: 10.3892/mmr.2014.2423

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  The Upregulation of hsa-mir-181b-1 and Downregulation of Its Target CYLD in the Late-Stage of Tumor Progression of Breast Cancer.

Authors:  Alireza Andalib; Shadi Rashed; Moein Dehbashi; Jamshid Hajati; Farshid Noorbakhsh; Mazdak Ganjalikhani-Hakemi
Journal:  Indian J Clin Biochem       Date:  2019-03-21

2.  MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.

Authors:  Lijuan Yao; Li Wang; Fengxia Li; Xihai Gao; Xuegong Wei; Zhihui Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Authors:  Yanbei Sun; Tingxiu Jiang; Yongqing Jia; Jingyun Zou; Xiaoxiao Wang; Weiying Gu
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

4.  Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.

Authors:  Jianing Wu; Abdulrahman Al-Zahrani; Ozal Beylerli; Rinat Sufianov; Rustam Talybov; Svetlana Meshcheryakova; Galina Sufianova; Ilgiz Gareev; Albert Sufianov
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 5.  Role of MicroRNAs in Malignant Glioma.

Authors:  Bao-Cheng Wang; Jie Ma
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

6.  FAMLF is a target of miR-181b in Burkitt lymphoma.

Authors:  J G Li; Y Ding; Y M Huang; W L Chen; L L Pan; Y Li; X L Chen; Y Chen; S Y Wang; X N Wu
Journal:  Braz J Med Biol Res       Date:  2017-05-04       Impact factor: 2.590

7.  Paeonol induces the apoptosis of the SGC‑7901 gastric cancer cell line by downregulating ERBB2 and inhibiting the NF‑κB signaling pathway.

Authors:  Jun Fu; Luhua Yu; Jie Luo; Rui Huo; Bing Zhu
Journal:  Int J Mol Med       Date:  2018-05-23       Impact factor: 4.101

8.  Phenytoin Inhibits Cell Proliferation through microRNA-196a-5p in Mouse Lip Mesenchymal Cells.

Authors:  Hiroki Yoshioka; Sai Shankar Ramakrishnan; Akiko Suzuki; Junichi Iwata
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

Review 9.  Advancing towards Effective Glioma Therapy: MicroRNA Derived from Umbilical Cord Mesenchymal Stem Cells' Extracellular Vesicles.

Authors:  Eko Ngadiono; Novi Silvia Hardiany
Journal:  Malays J Med Sci       Date:  2019-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.